endothelium releases various soluble factors including nitric oxide to induce vasodilation while also reducing platelet aggregation, white cell adhesion and proliferation of vascular smooth muscle. 11 Endothelial dysfunction is characterized by a reduction in this response, and multiple studies confirm that coronary artery endothelial dysfunction is associated with an increased incidence of adverse cardiovascular events. 10 12 13 The gold standard for identifying coronary artery endothelial dysfunction is the vasodilatory response to graded intra-coronary infusion of acetylcholine combined with quantitative coronary angiography and Doppler flow measurements. 8 14 However, endothelial dysfunction is a systemic disorder and less invasive methods have been developed and validated. 15 -17 The EndoPAT 2000 (Itamar Medical
Ltd, Caesarea, Israel) is an automated non-invasive device capable of detecting endothelial dysfunction using peripheral arterial tonometry (PAT) in response to reactive hyperaemia (RH-PAT index). The potential for rapid testing and relative operator independence 17 together with demonstrated reproducibility 18 represent potentially important strengths of this device. It is both approved by the US Food and Drug Administration and Conformité Européenne (CE) marked. Although previous studies have shown that the RH-PAT index identifies coronary artery endothelial dysfunction, 16 it is unknown whether this novel technique can provide information for cardiac risk stratification in patients undergoing non-cardiac surgery. We sought to determine whether endothelial dysfunction identified by an RH-PAT index could provide a useful risk-stratification tool for adverse cardiac events in at-risk adults undergoing non-cardiac surgery.
Methods
The study was carried out in two academic centres (Alfred Hospital, Melbourne, Australia and Prince of Wales Hospital, Hong Kong, China). After obtaining approval from the human research ethics committee of each participating institution and written informed consent from all participants, we conducted a prospective observational study in patients undergoing non-cardiac surgical procedures. Patients aged .40 yr and scheduled to undergo non-emergent surgery identified as intermediate or high risk for postoperative cardiac complications using American College of Cardiology/American Heart Association (ACC/AHA) guidelines 19 were screened.
In addition to routine preoperative evaluation and testing performed at the discretion of the attending physician, all study subjects underwent non-invasive endothelial function assessment using the automated EndoPAT 2000 device. The principles of PAT in response to reactive hyperaemia have been described. 20 In brief, it uses proprietary technology to measure the magnitude and dynamics of arteriolar tone changes in peripheral arterial beds non-invasively. A thimbleshaped pneumatic probe is applied to the tip of one finger on each hand where the volume of blood in the fingertip with each arterial pulsation is photoplethysmographically detected. After a brief period to establish baseline, an arterial pressure cuff is inflated on one arm to supra-systemic pressure for a period of 5 min. After cuff deflation, the hyperaemic response in the ipsilateral finger is evaluated, measuring the ratio of the pulse wave amplitude (PWA) in this period to baseline PWA. This ratio is further normalized to the signal simultaneously obtained from the contralateral arm, thus accounting for potential effects of systemic changes in vascular tone (Fig. 1) . A previous study reported an RH-PAT index of ,1.35 to be a useful indicator of coronary artery endothelial dysfunction. 16 In addition to baseline patient characteristics, data were collected on known or suspected risk factors for perioperative cardiac morbidity (PCM) or mortality and factors that can impact on endothelial function. The revised cardiac risk (Lee) index was calculated for each subject, 21 while the treating clinician further assessed each subject's level of risk as low, moderate, or high for each of surgery-specific factors, clinical predictors, and functional status reflecting AHA/ACC guidelines 19 providing a global, albeit more subjective, metric of clinicianperceived risk. Additional preoperative investigations to further stratify or attenuate cardiac risk were performed at the discretion of the treating physician as part of the preoperative evaluation. Serum troponin (Tn) was measured daily for the first 3 postoperative days with all management decisions at the discretion of the attending medical team. In Melbourne, Tn-I was measured with the Architect Stat System (Abbott Diagnostics, Lake Forrest, IL, USA), while in Hong Kong Tn-T was measured using the fourth-generation Elecsys assay (Roche diagnostics, Basel, Switzerland 
Statistical analysis
Statistical analyses were performed using Stata 12 (StataCorp, College Station, TX, USA). Continuous variables are presented as mean and standard deviation (SD) or median and interquartile range (IQR) according to distribution. Categorical variables are presented as counts and proportions. Receiver operator characteristic (ROC) curves were constructed to evaluate sensitivity, specificity, and diagnostic likelihood ratios of the RH-PAT index to identify subjects with the adverse outcomes of interest and to identify RH-PAT thresholds for defining endothelial dysfunction within the study cohort. Because of the inverse relationship between RH-PATand endothelial dysfunction, the inverse RH-PAT was used to generate ROC curves, maintaining the rank order of values, before converting values back into the original RH-PAT index format for further analysis. In the absence of existing and validated published data on perioperative RH-PAT measures, we defined endothelial dysfunction using thresholds identified from within the study cohort and based upon subjective determination of suitably balanced positive and negative diagnostic likelihood ratios and observed sensitivity and specificity. We compared the incidence of adverse outcomes defined in this way for subjects with and those without endothelial dysfunction. Logistic regression was used to determine the prognostic value of endothelial dysfunction and the Lee index, both alone and in combination, while the incremental value of adding endothelial dysfunction to the existing and readily available Lee index was assessed using the c-statistic and integrated discrimination indices (IDI). We also calculated the populationattributable risk for predictors of MINS and 30-day cardiac morbidity using the Interactive Risk Attributable Program (version 2.2, US National Cancer Institute, 2002). The risk indicates the proportion of cardiac morbidity potentially attributable to each risk factor if causality was established. 23 24 Cox regression analysis determined the association between endothelial dysfunction and time to hospital discharge after surgery. Subjects who died before discharge were assigned the longest observed time to discharge within the study cohort, ensuring that early in-hospital mortality did not spuriously reflect a favourable outcome. 25 Hazard ratios (HRs) represent the likelihood of discharge on any given day such that a HR of ,1 indicates a lower discharge rate compared with a reference group of patients without endothelial dysfunction. Results are presented as odds ratios (ORs) or HR and 95% confidence interval (CI) with P,0.05 considered significant.
Sample size
Based on a previous study of endothelial dysfunction, 26 we assumed a 2:1 distribution of normal and abnormal endothelial function within the study cohort and anticipated a 3% event rate for the primary outcome in subjects with normal endothelial function. Allowing for a type I error rate of 0.05, a sample size of 240 subjects was expected to provide power .80% to detect an event rate of ≥15% in subjects with endothelial dysfunction.
Results
Between July 2007 and February 2010, we enrolled 249 subjects; after withdrawals and exclusions, 238 remained in the study cohort for analysis (Fig. 2) . The median RH-PAT index was 1. Table S1 ). The RH-PAT index was lower in subjects Endothelial function for preoperative risk assessment with diabetes mellitus or hypertension and higher in subjects identified as current smokers or with hypercholesterolaemia, but did not differ according to either gender or preoperative use of statins. The mean duration of surgery was 226 (101) min with a median estimated blood loss of 300 (150 -600) ml and a mean i.v. fluid administration (crystalloid or colloid) of 2620 (1450) ml. By postoperative day 3, 35 subjects (14.7%) had at least one recorded Tn value of ≥0.04 mg litre 21 . Tn (+) patients were older and more likely to be current smokers, have a history of hypertension, receive preoperative statin therapy, or have a first-degree relative with coronary disease. Additionally, they had increased 30-day mortality and increased hospital length of stay after surgery, outcomes that did not differ according to study site for these subjects (Table 1) . Thirty-eight subjects (16.0%) met the criteria for 30-day PCM. ROC curves were constructed to evaluate the diagnostic performance characteristics of the RH-PAT index for adverse outcomes of interest. RH-PAT provided limited discrimination for identifying subjects with MINS (ROC AUC 0.60, 95% CI 0.47 -0.73); a value of ≤1.22 provided sensitivity and specificity of 31 and 96%, respectively, with a positive diagnostic likelihood ratio of 8.0 (Fig. 3 ). For the same outcome, the Lee index yielded an ROC AUC of 0.70 (95% CI 0.61-0.79) with sensitivity and specificity of 80 and 59%, respectively, and a positive diagnostic likelihood ratio of 1.9 using a threshold value of ≥2 (Table 2) . Substituting 30-day PCM as the outcome of interest produced only minor change to ROC summary measures. RH-PATdiscriminant utility appeared to vary by site, despite allowing sitespecific thresholds to define endothelial dysfunction for subgroup analyses: HK ROC AUC for MINS 0.89, 95% CI 0.81 -0.96; Melbourne ROC AUC for MINS 0.47, 95% CI 0.30-0.65 (see Supplementary Appendix Table S2 , Supplementary Fig. S1 ).
Incidence of MINS was higher in subjects with endothelial dysfunction (57.9% vs 11.0%, P¼0.001), remaining consistent for the outcome of PCM. Similarly, there was a trend towards increased incidence of adverse outcomes across increasing Lee index categories (see Supplementary Appendix Table S3 ). Endothelial dysfunction was a potent predictor of MINS (OR 11.2, 95% CI 4.1-30.5, P¼0.001), although the magnitude of this association was attenuated and was non-significant when restricted to the Melbourne subgroup only despite using a higher site-specific threshold to define endothelial dysfunction (see Supplementary Appendix Tables S4 and S5 ). After adjusting for age, Lee index and other evidence of more extensive surgery, endothelial dysfunction remained a potent risk factor for adverse cardiac outcomes with populationattributable risk analysis suggesting .40% of MINS related to the presence of endothelial dysfunction (Table 3; see Supplementary Appendix Table S6 ). Repeat analysis using the Lee index as a four-point ordinal variable (0, 1, 2, and ≥3) did not materially alter these results.
Using the RH-PAT threshold for endothelial dysfunction of ≤1.22 and a Lee index of ≥2, we further identified subpopulations designated RH-PAT(2)/Lee(2), RH-PAT(2)/Lee(+), RH-PAT(+)/Lee(2), and RH-PAT(+)/Lee(+). In the setting of discordant results for these two risk-stratification methods, the presence of either indicator was consistently associated with adverse outcomes. However, in the presence of both, the risk of MINS (OR 51.8, 95% CI 11.8-227, P¼0.001) or 30-day PCM (OR 76.7, 95% CI 15.9-369, P¼0.001) was greatly elevated compared with baseline (Table 4) .
Changes in c-statistic together with IDI were used to assess the incremental value in risk classification provided by the addition of RH-PAT endothelial dysfunction to the Lee index. Addition of RH-PAT-defined endothelial dysfunction to a Lee index of ≥2 improved the c-statistic from 0.69 to 0.77 for the outcome of MINS with an IDI (0.11, P¼0.003) consistent with enhanced risk classification (Table 5 ). Repeat analysis using the Lee index as a four-point ordinal variable (0, 1, 2, and ≥3) did not materially alter these results.
Adjusted for Lee index, age, and other evidence of more extensive surgery, endothelial dysfunction was associated with a markedly reduced likelihood of discharge from hospital on any given day after surgery (HR 0.39, 95% CI 0.23 -0.65, P¼0.001) ( Table 6 ). When the impact of discordant results was assessed, the likelihood of hospital discharge on any given day after surgery tended to decrease in patients with endothelial dysfunction regardless of Lee classification status, while, in the absence of endothelial dysfunction, a Lee index of ≥2 demonstrated no association with time to discharge (see Supplementary Appendix Table S7 ). Endothelial function for preoperative risk assessment surgery, did not improve the prognostic value of endothelial dysfunction for either of the measured adverse cardiac outcomes.
Discussion
Preoperative endothelial dysfunction identified by a rapid, automated and non-invasive detection technique was associated with an increased incidence of postoperative Tn elevation consistent with myocardial injury. Endothelial dysfunction appeared to provide additional risk stratification over and above that achieved with the Lee index. However, utility of this non-invasive measure of endothelial dysfunction was characterized by marked inter-site variation that remains unexplained and that might limit its widespread perioperative application. The vascular endothelium is important in cardiovascular health and disease. 8 -10 13 27 Through release of soluble factors including nitric oxide, it can promote vasodilation and limit platelet aggregation or the progression of atherosclerosis. 8 Multiple studies confirm that endothelial dysfunction can predict longerterm adverse cardiovascular outcomes, 10 12 13 28 29 while post--mortem studies suggest that many perioperative myocardial infarctions are attributable to unstable vascular plaque 6 7 potentially missed by conventional preoperative stress testing for inducible ischaemia secondary to flow-limiting stenoses. However, a role for preoperative endothelial function assessment as a risk-stratification tool remains inadequately explored. Endothelial function defined by brachial artery flowmediated dilation (FMD) yielded sensitivity and specificity of 89 and 40%, respectively, with an odds ratio of 3.7 for a composite perioperative outcome that included cardiac death, myocardial infarction, stroke, or Tn-I .0.4 ng ml 21 in 187 patients undergoing elective vascular surgery. 26 While the greater prognostic ability of endothelial dysfunction for MINS in the current study suggests a better utility for the RH-PAT index, this could simply reflect the lower threshold of our highly specific biochemical end-point or differing thresholds for defining endothelial dysfunction. While the findings of the two studies are as broadly consistent, the earlier study provided only limited assessment for the utility of combining endothelial function testing with other risk factors. Furthermore, the technique of brachial artery FMD is labour-intensive and results are significantly operator dependent, making it unsuited to wide spread clinical use as a preoperative screening technique for cardiovascular risk stratification. 9 30 In contrast, the RH-PAT index is faster and automated to minimize operator dependency, and studies confirm an association between RH-PAT and both coronary artery endothelial dysfunction and adverse cardiovascular events. 16 29 Despite adjusting for other potential confounding variables, including the Lee index, endothelial dysfunction was associated with a .10-fold increase in odds for MINS. Although the Lee index likely represents the best validated and most accurate predictive generic risk index currently available, 4 the enhanced c-statistic and integrated discrimination improvement seen with addition of RH-PAT-defined endothelial Area under the ROC curve. ROC curves were generated using inverse RH-PAT index values to ensure that higher numbers represented more severe endothelial dysfunction. These numbers have been converted back into their original format to identify RH-PATcut-points and for all subsequent analyses. dysfunction to the Lee index suggest improved risk classification for adverse perioperative cardiac outcomes. Additionally, the apparent synergistic prognostic capacity when endothelial dysfunction was combined with Lee index ≥2 suggests that the value of preoperative endothelial function testing might be enhanced if selectively utilized in patients identified as highrisk surgical candidates by an easily applied clinical risk score. Our data support the concept that endothelial dysfunction represents an integrated barometer of vascular heatlh, 9 31 providing important additional information regarding perioperative risk not captured by clinical parameters of the Lee index. However, a minority of subjects underwent conventional cardiac stress testing in the current study, and the potential prognostic value of combining the RH-PAT vascular functional measure with measures of anatomic flow limitation identified by conventional stress testing remains unknown. Nevertheless, with .40% of MINS potentially attributable to a link with endothelial dysfunction, important questions are raised regarding the possibility of effective preoperative risk modification through interventions to reverse endothelial dysfunction. Previous authors have speculated that pleiotropic effects of statins might improve or reverse endothelial dysfunction. 27 32 Such an effect might contribute to the reduced risk of adverse cardiac events after non-cardiac surgery reported in several observational studies 33 34 while also providing an opportunity for trials of targeted risk-reduction strategies. However, in the Endothelial function for preoperative risk assessment current study subjects receiving statins showed no difference in RH-PATmeasured endothelial function compared with those not receiving statins, and had an increased incidence of MINS. In an observational study, these findings could be explained by unrecognized or unmeasured confounding by indication. The current study was not powered to measure predictive utility for hard end-points such as perioperative MI or 30-day mortality. However, multiple studies confirm the significance of even small elevations in Tn, suggesting that such elevations are associated with increased adverse outcomes with no lower limit below which they can be considered benign. 1 35 36 Despite the absence of preoperative baseline Tn measurements, the recent VISION study strongly supports the prognostic value of isolated low-level postoperative Tn elevations. 1 While our primary end-point might also be criticized for combining results from different biochemical assays, the selected threshold values for each study site were based upon manufacturer and participating laboratory standards together with recently published guidelines to pragmatically identify MINS. 37 However, the selected threshold for Tn-T (near the 10% CV for the assay) was greater than the manufacturer-reported 99th centile for a normal population, potentially contributing to the lower incidence of MINS observed in the Hong Kong cohort. Nevertheless, outcomes associated with identified MINS were not significantly different between study sites leaving any differences in end-point detection of uncertain clinical significance. Unanticipated inter-site variation creates concern regarding the interpretation and generalizability of our findings. Although RH-PAT indices were higher, and by inference endothelial function better in the Melbourne cohort, the incidence of MINS was more than two-fold higher than in the Hong Kong cohort. In contrast, despite the lower incidence of adverse outcomes, it was the Hong Kong subgroup where endothelial dysfunction identified by the RH-PAT index appeared to dramatically improve risk stratification. While the suggested greater sensitivity of the Tn-I assay used in the Melbourne cohort might contribute to these results, 38 39 a potential role for genetic variation between study sites should also be considered. However, regional or ethnic variations in RH-PAT indices have not been previously described, and it is unclear whether the use of population-specific thresholds to define endothelial dysfunction is a valid approach. Nevertheless, using a site-specific RH-PAT threshold to define endothelial dysfunction, there was a generally consistent trend within the Melbourne subgroup towards effective risk stratification and unanticipated subgroup differences should be interpreted with caution. 40 41 Alternatively, despite the automated and relative operator-independent nature of the EndoPAT device, it remains uncertain to what extent variations in other baseline characteristics and risk factors, patient activity before testing, differences in environmental conditions at the time of testing or unmeasured operator variability where manual adjustment of parameters for analysis was required contributed to observed inter-site differences in EndoPAT results. Although speculative, such differences in baseline risk factors, genetic variation, EndoPAT 2000 testing procedures, and even biological mechanisms for MINS might all have contributed to the wide inter-site variation in prognostic utility of endothelial dysfunction. Additional comparative measures of endothelial function such as brachial artery FMD might aid in the interpretation of inter-site variability in prognostic utility of EndoPAT. Our study has a number of additional strengths and limitations. It was a prospective study with pre-specified endpoints, thus limiting the risk of ascertainment bias. The inclusion criteria were broad, attempting to increase generalizability of results. Although a proportion of subjects underwent less extensive surgery than anticipated at the time of enrolment, the 14.7% incidence of MINS in the study cohort is consistent with high-risk surgery. While previous research suggests an acceptable level of reproducibility for EndoPAT results, 18 this has not been demonstrated in a preoperative population considered at-risk for adverse cardiac events. Nevertheless, rapid and relatively operator-independent assessment of endothelial dysfunction makes the EndoPAT device practical for preoperative screening, and the large inter-individual variability in results is consistent with previous studies. 29 42 43 The datadriven analysis used in the current study can be justified by limited existing data on the use of this novel technique for perioperative risk stratification. However, our results must still be interpreted with caution and the study should be viewed as exploratory in nature.
In conclusion, we demonstrated the potential utility of a noninvasive automated measure of endothelial dysfunction to provide rapid and effective preoperative risk stratification, both alone and synergistically when combined with an existing clinical risk score, for perioperative myocardial injury in patients undergoing non-cardiac surgery. However, marked inter-site variation in results remains poorly understood and might limit the utility of this device in a clinical setting. Larger clinical trials using a priori specified thresholds to define endothelial dysfunction are now warranted to understand this regional variation better and further evaluate its ability to improve preoperative risk stratification and perioperative outcomes. 
